A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is researching an experimental drug called odronextamab (referred to as study drug), in combination with lenalidomide. The study is focused on participants who have one of two types of cancer: Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL) that has come back after treatment (called "relapsed") or did not respond to treatment (called "refractory"). FL and MZL are subtypes of Non-Hodgkin 's Lymphoma (NHL). This study will be made up of two parts (Part 1 not randomized, Part 2 randomized - controlled). The aim of Part 1 of the study is to see how safe and tolerable the study drug is when used in combination with lenalidomide, in participants with FL or MZL, and to determine the dose of the study drug to be used in Part 2 of this study. This combination is considered "first-in-human" as it has not been tested as a combination treatment in humans before. The aim of Part 2, of the study is to assess how well the combination of the study drug and lenalidomide works compared to the combination of rituximab (called "the comparator drug") and lenalidomide. The combination of comparator drug and lenalidomide is the current standard-of-care treatment for relapsed/refractory FL and/or MZL. Standard-of-care means the usual medication expected and used when receiving treatment for a condition. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug in combination with lenalidomide * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects) * The impact from the study drug on quality-of-life and ability to complete routine daily activities
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony histologicznie chłoniak pęcherzykowy (stopnie 1-3a) lub chłoniak marginalny
- •Choroba, która wróciła po leczeniu lub nie odpowiada na leczenie, po co najmniej jednej wcześniejszej terapii
- •Wcześniejsze leczenie musiało zawierać przeciwciało anty-CD20
- •Widoczne guzły potwierdzone na badaniu tomograficznym (CT lub MRI)
- •Ogólny stan zdrowia pozwalający na uczestnictwo w badaniu (ECOG 0-2)
- •Prawidłowe funkcje krwi i narządów
- •Zrozumienie zagrożenia dla płodu związanego z lenalidomydem i zgodę na środki ostrożności
✗ Disqualifies
- •Chłoniak mózgu lub jego zmiany w mózgu
- •Wcześniejszy lub obecny chłoniak wysokozłośliwy lub inny typ niż określony w kryteriach włączenia
- •Choroby ośrodkowego układu nerwowego
- •Inny nowotwór (z wyjątkami: rak prostaty leczony hormonalnie, lub nowotwór nieaktywny przez 3+ lata)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (171)
David Geffen School of Medicine at UCLA
Los Angeles, United States
Boca Raton Clinical Research (BRCR) Global
Plantation, United States
Indiana University and Comprehensive Cancer Center
Indianapolis, United States
Hattiesburg Clinic
Hattiesburg, United States
Dartmouth Cancer Center
Lebanon, United States
Stony Brook University Hospital
Stony Brook, United States
Clinical Research Alliance Inc
Westbury, United States
Prohealth Care Inc
Waukesha, United States
Liverpool Hospital
Liverpool, Australia
Calvary Mater Newcastle
Waratah, Australia
Pindara Private Hospital
Benowa, Australia
Royal Hobart Hospital
Hobart, Australia
Epworth Freemasons
East Melbourne, Australia
Ordensklinikum Linz
Linz, Austria
Kepler University Hospital
Linz, Austria
Medical University Vienna
Vienna, Austria
Klinikum Wels-Grieskirchen
Wels, Austria
Centre Hospitalier Universitaire at Universite Catholique de Louvain Namur
Yvoir, Belgium
Universitair Ziekenhuis (UZ) Gent/ Ghent University Hospital
Ghent, Belgium
Algemeen Ziekenhuis AZ Delta
Roeselare, Belgium
Ziekenhuis Netwerk Antwerpen Stuivenberg
Antwerp, Belgium
Institut Jules Bordet
Brussels, Belgium
Hospital Sao Rafael
Salvador, Brazil
Hospital Sirio Libanes Brasilia
Brasília, Brazil
Uopeccan Hospital do Cancer de Cascavel
Cascavel, Brazil
Hospital Erasto Gaertner
Curitiba, Brazil
Hospital de Clinicas de Porto Alegre
Porto Alegre, Brazil
Centro Gaucho Integrado
Porto Alegre, Brazil
Amaral Carvalho Hospital
Jaú, Brazil
Instituto Nacional de Cancer Jose Alencar Gomes da Silva
Rio de Janeiro, Brazil
Hospital Sirio Libanes
São Paulo, Brazil
A Beneficencia Portuguesa de Sao Paulo, Oncology House
São Paulo, Brazil
University Hospital Hradec Kralove
Hradec Králové, Czechia
Fakultni Nemocnice Brno
Brno, Czechia
University Hospital Kralovske Vinohrady
Prague, Czechia
Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
Institut Paoli-Calmettes
Marseille, France
CHU de Rennes
Rennes, France
Centre Hospitalier Regional Universitaire de Tours
Tours, France
Polyclinique Bordeaux Nord Aquitaine
Bordeaux, France
Centre Francois Magendie
Pessac, France
Hopital Saint Vincent-de-Paul
Lille, France
Centre Henri Becquerel
Rouen, France
Nantes University Hospital
Nantes, France
Centre Hospitalier Metropole Savoie
Chambéry, France
Centre Hospitalier d'Avignon
Avignon, France
Centre Hospitalier Universitaire (CHU) Montpellier
Montpellier, France
Hopital Saint Louis
Paris, France
Assistance Publique-Hopitaux de Paris (AP-HP)
Paris, France
Institut Curie
Saint-Cloud, France
Hopital Victor Dupouy Argenteuil
Argenteuil, France
Avicenne Hospital
Bobigny, France
Gustave Roussy
Villejuif, France
Stauferklinikum
Mutlangen, Germany
Robert-Bosch-Krankenhaus
Stuttgart, Germany
LMU Klinikum
Munich, Germany
TUM Fakultat fur Medizin - Klinikum Rechts der Isar
Munich, Germany
Clinic Frankfurt (Oder)
Frankfurt am Main, Germany
University Hospital Essen
Essen, Germany
Universitatsmedizin der Johannes-Gutenberg Universitat Mainz
Mainz, Germany
University Hospital Halle Saale
Halle, Germany
Stadtisches Krankenhaus Kiel
Kiel, Germany
MVZ fuer Haematologie und Onkologie Rhein-Kreis GmbH
Neuss, Germany
Assuta Ashdod Medical Center
Ashdod, Israel
Hadassah Medical Center
Jerusalem, Israel
Galilee Medical Center
Nahariya, Israel
Rabin Medical Center
Petah Tikva, Israel
Chaim Sheba Medical Center
Ramat Gan, Israel
The Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Assuta Medical Centers
Tel Aviv, Israel
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Meldola, Italy
Ospedale Policlinico San Martino IRCCS
Genoa, Italy
S Gerardo Hospital
Monza, Italy
A.O.U. Citta della Salute e della Scienza di Torino
Turin, Italy
Centro Di Riferimento Oncologico (CRO), Aviano, National Cancer Institute
Aviano, Italy
Candiolo Cancer Institute, FPO, IRCCS
Candiolo, Italy
University of Bologna Dipartimento di Medicina Specialistica Diagnostica e Sperimentale
Bologna, Italy
Azienda Ospedaliera Spedali Civili di Brescia
Brescia, Italy
ASST Grande Ospedale Metropolitano Niguarda - Main Address
Milan, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
Istituto Europeo di Oncologia
Milan, Italy
A.O.U. di Modena
Modena, Italy
Federico II University
Naples, Italy
AOU Maggiore della Carita
Novara, Italy
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy
Azienda Ospedaliera di Perugia
Perugia, Italy
Ospedale Santa Maria delle Croci
Ravenna, Italy
Santa Maria della Misericordia
Udine, Italy
Hospital Sultanah Aminah Jhor Bahru
Johor Bahru, Malaysia
University of Malaya Medical Centre
Kuala Lumpur, Malaysia
Hospital Queen Elizabeth
Kota Kinabalu, Malaysia
Hospital Ampang
Ampang, Malaysia
Subang Jaya Medical Center
Subang Jaya, Malaysia
In-Vivo Sp. z o.o.
Bydgoszcz, Poland
Specjalistyczny Szpital im A. Sokolowskiego w Walbrzychu
Wałbrzych, Poland
Uniwersytecki Szpital Kliniczny
Wroclaw, Poland
Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie, Centrum Innowacyjnych Terapii
Lublin, Poland
Pratia MCM Krakow
Krakow, Poland
Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
Pratia Poznan Medical Center
Poznan, Poland
Aidport
Skorzewo, Poland
Szpital Uniwersytecki Nr2 Bydgoszcz
Bydgoszcz, Poland
Pratia Onkologia Katowice
Katowice, Poland
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. Mikolaja Kopernika w Lodzi (Copernicus Memorial Hospital)
Lodz, Poland
Narodowy Instytut Onkologii
Warsaw, Poland
St. Vincents Hospital - The Catholic University of Korea
Suwon, South Korea
Jeonbuk National University Hospital
Jeonju, South Korea
Gachon University Gil Medical Center
Incheon, South Korea
Inje University Busan Paik Hospital
Busan, South Korea
Pusan National University Hospital
Busan, South Korea
Yeyungnam University Medical Center
Daegu, South Korea
Yonsei University Health System
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Yeouido St. Marys Hospital
Seoul, South Korea
Seoul St Marys Hospital
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Ulsan University Hospital
Ulsan, South Korea
University Hospital of Santiago de Compostela
Santiago de Compostela, Spain
Son Espases University Hospital
Palma, Spain
Institut Catala d'Oncologia
L'Hospitalet de Llobregat, Spain
Hospital Universitario Marques de Valdecilla
Santander, Spain
Hospital Universitario Quironsalud Madrid
Pozuelo de Alarcón, Spain
Hospital Universitario Central de Asturias
Oviedo, Spain
University Hospital Vall d'Hebron
Barcelona, Spain
Hospital Clinic de Barcelona
Barcelona, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital Virgen De Las Nieves De Granada
Granada, Spain
Hospital Universitario Ramon y Cajal
Madrid, Spain
Fundacion Jimenez Diaz University Hospital
Madrid, Spain
Hospital Universitario12 de Octubre
Madrid, Spain
Hospital Universitario HM Sanchinarro
Madrid, Spain
Hospital Universitario de Salamanca
Salamanca, Spain
University Hospital Virgen del Rocio
Seville, Spain
Instituto Valenciano de Oncologia
Valencia, Spain
University Hospital Doctor Peset
Valencia, Spain
Chang Gung Medical Foundation Chia Yi Branch
Buzi, Taiwan
Changhua Christian Hospital
Changhua, Taiwan
Show Chwan Memorial Hospital
Changhua, Taiwan
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Taipei Medical University - Shuang Ho Hospital
New Taipei City, Taiwan
National Cheng Kung University Hospital
Tainan, Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Tri-Service General Hospital
Taipei, Taiwan
Taipei Municipal Wan Fang Hospital
Taipei, Taiwan
Chang Gung Memorial Hospital
Taoyuan City, Taiwan
Chulalongkorn University
Bangkok, Thailand
Sriraj Hospital
Bangkok, Thailand
Chiang Mai University
Chiang Mai, Thailand
Ankara University Faculty of Medicine
Mamak, Turkey (Türkiye)
Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
Yenimahalle, Turkey (Türkiye)
Gazi University
Ankara, Turkey (Türkiye)
VM Medical Park Mersin Hospital
Mezitli, Turkey (Türkiye)
Tekirdag Namik Kemal University Hospital
Tekirdağ, Turkey (Türkiye)
Istanbul University, Istanbul Medical Faculty
Istanbul, Turkey (Türkiye)
Ege University
Izmir, Turkey (Türkiye)
Dokuz Eylul University
Izmir, Turkey (Türkiye)
Sakarya University Medical Faculty
Sakarya, Turkey (Türkiye)
Ondokuz Mayıs University
Samsun, Turkey (Türkiye)
Zonguldak Bulent Ecevit University
Zonguldak, Turkey (Türkiye)
Royal Cornwall Hospitals NHS Trust, Royal Cornwall Hospital
Truro, United Kingdom
Derriford Hospital and the Royal Eye Infirmary
Plymouth, United Kingdom
University Hospitals Dorset
Bournemouth, United Kingdom
Salisbury Foundation Trust
Salisbury, United Kingdom
The Hillingdon Hospital
Uxbridge, United Kingdom
The Royal Marsden NHS Foundation Trust
Sutton, United Kingdom
James Paget University Hospitals NHS Foundation Trust
Great Yarmouth, United Kingdom
Barking, Havering and Redbridge University Hospitals NHS Trust
Romford, United Kingdom
South Warwickshire NHS Foundation Trust
Warwick, United Kingdom
Trial contact
Clinical Trials Administrator
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.